Feasibility and efficacy of 8 week Glecaprevir/Pibrentasvir to treat incarcerated viraemic HCV patients: A case-control study.
Authors: Flower v
Date: 21 Feb 2023
Scope of interest: infectious diseases/penitentiary health
Authors: Flower v
Date: 21 Feb 2023
Scope of interest: infectious diseases/penitentiary health
Authors: A.M. Abbatecola, M. Russo, C. Bettuzzi, B. Morganti, C. Romaniello, T. Micheli, L. Di Cioccio, F. Lattanzio
Date: 2012
Scope of interest: Nutrition, Dementia
Authors: Casciato S, Morano A, Fattouch J, Fanella M, Ivory F, Albini M, Basili LM, Cerulli Irelli E, Viganò A, De Risi M, Grammaldo LG, D'Aniello A, Mascia A, Manfredi M, Quarato P, Giallonardo AT, Di Gennaro G, Di Bonaventura C.
Date: 2018
Scope of interest: Epilepsy/autoimmune diseases of the CNS
Authors: Judge T, Lombardi F, Santorelli FM, Kawarai T, Orlacchio A.
Date: 2014
Scope of interest: Neurogetics
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide